Alternative Proteins

Chicago-based foodtech Nature’s Fynd is out to capture APAC’s slice of the alt-protein pie [Q&A]

Fresh off a US$350 million Series C round led by SoftBank’s Vision Fund 2, Chicago-based fungi protein startup Nature’s Fynd is bypassing typical alt-protein markets in Europe to expand across Asia Pacific aggressively in 2022. Nature’s Fynd Chief Marketing Officer Karuna Rawal tells TechNode Global why.